Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on September 29, 2017. The filing discloses specific corporate governance changes and executive appointments effective in late September and early October 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
- Change in Duties: Dr. Gregoire Cosendai was appointed Vice President of Clinical Affairs on September 29, 2017. He previously served as Vice President of European Operations. His new role involves directing clinical activities for the Orion I device and all other company clinical operations, reporting to CEO Will McGuire.
- New Appointment: Effective October 1, 2017, the Company retained Frank Vandeputte as Vice President and General Manager for EMEA and Asia Pacific. He will oversee sales and marketing outside North America and report to CEO Will McGuire.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of material risks and contingencies. The document is limited to reporting the specific executive appointments and role changes described above.
Investor Verification Checklist
- Verify the correct registrant name is Second Sight Medical Products, Inc., not Vivani Medical, Inc.
- Confirm the effective dates of the new roles: Dr. Cosendai (Sept 29, 2017) and Mr. Vandeputte (Oct 1, 2017).
- Review the scope of Dr. Cosendai's new clinical oversight regarding the Orion I device.
- Check subsequent filings for any financial impact related to these executive changes.